Search research articles
Contact Us
Filters
Showing results (61-70 of 73) with videos related to
Page
of 8
Sort By:
Haematologica
|
March 20, 2025
Recognition, prevention, and management of adverse events associated with asparaginase / pegaspargase treatment of acute lymphoblastic leukemia in adults: consensus of an expert panel
Emily Curran, Marlise R Luskin, Houda Alachkar, et al.
Scientific Reports
|
March 7, 2019
Effect of CHK1 Inhibition on CPX-351 Cytotoxicity in vitro and ex vivo
Nicole D Vincelette, Husheng Ding, Amelia M Huehls, et al.
Haematologica
|
February 10, 2022
Outcome of relapsed or refractory acute B-lymphoblastic leukemia patients and <i>BCR-ABL</i>-positive blast cell crisis of B-lymphoid lineage with extramedullary disease receiving inotuzumab ozogamicin
Sabine Kayser, Chiara Sartor, Marlise R Luskin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 7, 2014
Pattern of frequent but nontargeted pharmacologic thromboprophylaxis for hospitalized patients with cancer at academic medical centers: a prospective, cross-sectional, multicenter study
Jeffrey I Zwicker, Adam Rojan, Federico Campigotto, et al.
The Journal of Biological Chemistry
|
September 8, 2012
Chaperone activity of small heat shock proteins underlies therapeutic efficacy in experimental autoimmune encephalomyelitis
Michael P Kurnellas, Sara E Brownell, Leon Su, et al.
Leukemia & Lymphoma
|
April 5, 2022
Genomic landscape of myelodysplastic/myeloproliferative neoplasm can predict response to hypomethylating agent therapy
Theodoros Karantanos, Hua-Ling Tsai, Lukasz P Gondek, et al.
Haematologica
|
June 11, 2026
Evolution to complex karyotype disease in mono-allelic <i>TP53</i>-mutated myelodysplastic syndrome/acute myeloid leukemia: a cohort study
Priyanka Fernandes, Sergiu Pasca, Tania Jain, et al.
Cancer Medicine
|
November 14, 2023
A phase 2 and pharmacological study of sapanisertib in patients with relapsed and/or refractory acute lymphoblastic leukemia
Aref Al-Kali, Ibrahim Aldoss, Pamela J Atherton, et al.
Haematologica
|
December 7, 2023
Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease
Sabine Kayser, Chiara Sartor, Fabio Giglio, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 9, 2021
Nonmyeloablative Allogeneic Transplantation With Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia With IDH Mutations: A Single Center Experience
Alexander Ambinder, Matthew Smith, Hua-Ling Tsai, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 73) with videos related to
Sort By:
Page
of 8
Haematologica
|
March 20, 2025
Recognition, prevention, and management of adverse events associated with asparaginase / pegaspargase treatment of acute lymphoblastic leukemia in adults: consensus of an expert panel
Emily Curran, Marlise R Luskin, Houda Alachkar, et al.
Scientific Reports
|
March 7, 2019
Effect of CHK1 Inhibition on CPX-351 Cytotoxicity in vitro and ex vivo
Nicole D Vincelette, Husheng Ding, Amelia M Huehls, et al.
Haematologica
|
February 10, 2022
Outcome of relapsed or refractory acute B-lymphoblastic leukemia patients and <i>BCR-ABL</i>-positive blast cell crisis of B-lymphoid lineage with extramedullary disease receiving inotuzumab ozogamicin
Sabine Kayser, Chiara Sartor, Marlise R Luskin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 7, 2014
Pattern of frequent but nontargeted pharmacologic thromboprophylaxis for hospitalized patients with cancer at academic medical centers: a prospective, cross-sectional, multicenter study
Jeffrey I Zwicker, Adam Rojan, Federico Campigotto, et al.
The Journal of Biological Chemistry
|
September 8, 2012
Chaperone activity of small heat shock proteins underlies therapeutic efficacy in experimental autoimmune encephalomyelitis
Michael P Kurnellas, Sara E Brownell, Leon Su, et al.
Leukemia & Lymphoma
|
April 5, 2022
Genomic landscape of myelodysplastic/myeloproliferative neoplasm can predict response to hypomethylating agent therapy
Theodoros Karantanos, Hua-Ling Tsai, Lukasz P Gondek, et al.
Haematologica
|
June 11, 2026
Evolution to complex karyotype disease in mono-allelic <i>TP53</i>-mutated myelodysplastic syndrome/acute myeloid leukemia: a cohort study
Priyanka Fernandes, Sergiu Pasca, Tania Jain, et al.
Cancer Medicine
|
November 14, 2023
A phase 2 and pharmacological study of sapanisertib in patients with relapsed and/or refractory acute lymphoblastic leukemia
Aref Al-Kali, Ibrahim Aldoss, Pamela J Atherton, et al.
Haematologica
|
December 7, 2023
Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease
Sabine Kayser, Chiara Sartor, Fabio Giglio, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 9, 2021
Nonmyeloablative Allogeneic Transplantation With Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia With IDH Mutations: A Single Center Experience
Alexander Ambinder, Matthew Smith, Hua-Ling Tsai, et al.
Page
of 8